Drug Chatter -- Tracking biopharma stock chatter

Profile for Alnylam Pharmaceuticals, Inc. (ALNY)

« Back to company index

ALNY Chatter Timeline

Stock Ticker for ALNY

Most Active Tweeters for ALNY

UserTweets
@TickerReport 12
@WKRBNews 9
@WatchlistN 9
@chaffeybreeze 8
@intercooleronli 8

Recent Tweets for ALNY

chaffeybreeze @chaffeybreeze
Alnylam Pharmaceuticals, Inc. $ALNY Receives Average Rating of “Buy” from Brokerages https://t.co/gmR6ZSAAAq
July 19th 2017, 9:07pm
IRAMarketReport @IRAMarketReport
Alnylam Pharmaceuticals, Inc. $ALNY Receives Average Rating of “Buy” from Brokerages https://t.co/fQqmXTL2u6
July 19th 2017, 9:07pm
dailymailtimes @dailymailtimes
Alnylam Pharmaceuticals, Inc. $ALNY Receives $82.41 Average PT from Analysts https://t.co/ot1NIbjAPY
July 19th 2017, 9:07pm
QuantchaIdeas @QuantchaIdeas
Covered Call Alert: ALNYLAM PHARMACEUTICALS $ALNY returning up to 15.40% through 19-Jan-2018 https://t.co/AmqLFXCTRW https://t.co/Y5Sc7D7rwY
July 19th 2017, 12:07pm
Regencells @Regencells
Who Are Non H2 Key Players of Alcoholic Steatohepatitis Pipeline (NASH)? https://t.co/DMRL8XUiPU #NASH $ALBO $ALNY https://t.co/qe68vqoJ53
July 19th 2017, 12:07pm
WKRBNews @WKRBNews
Alnylam Pharmaceuticals, Inc. $ALNY Given a $90.00 Price Target by Ladenburg Thalmann Financial Services Analysts https://t.co/SP9md94QHE
July 19th 2017, 8:07am
emq_news @emq_news
Alnylam Pharmaceuticals, Inc. $ALNY Downgraded to Hold at Zacks Investment Research https://t.co/UkF4SGW9VC
July 19th 2017, 8:07am
chaffeybreeze @chaffeybreeze
Alnylam Pharmaceuticals, Inc. $ALNY Expected to Announce Earnings of -$1.20 Per Share https://t.co/umGixKOQCT
July 18th 2017, 8:07pm
IRAMarketReport @IRAMarketReport
Alnylam Pharmaceuticals, Inc. $ALNY Expected to Announce Earnings of -$1.20 Per Share https://t.co/lXnGcY3u4B
July 18th 2017, 8:07pm
dailypoliticaln @dailypoliticaln
$22.22 Million in Sales Expected for Alnylam Pharmaceuticals, Inc. $ALNY This Quarter https://t.co/tpEeChCWGq
July 18th 2017, 6:07pm
midetimes @midetimes
$22.22 Million in Sales Expected for Alnylam Pharmaceuticals, Inc. $ALNY This Quarter https://t.co/us5BMuF4rt
July 18th 2017, 6:07pm
dakotafinancial @dakotafinancial
Rockefeller Financial Services Inc. Sells 174,165 Shares of Alnylam Pharmaceuticals, Inc. $ALNY https://t.co/MGNbExAzoN
July 18th 2017, 3:07pm
masterlongevity @masterlongevity
@RNAiAnalyst How do you think $ions and $alny will price their TTR amyloidosis therapies.I think will need to be >… https://t.co/xlviHb4BHG
July 18th 2017, 11:07am
intercooleronli @intercooleronli
Alnylam Pharmaceuticals $ALNY – Research Analysts’ Recent Ratings Updates https://t.co/ewyAbqv3gI
July 18th 2017, 10:07am
RNAiAnalyst @RNAiAnalyst
Maybe he didn't review $ALNY data indeed showing trouble w/ dose-response, hardly outside 'normal range':… https://t.co/pUiPzEtcre
July 18th 2017, 6:07am
navelhunt @navelhunt
@RNAiAnalyst Blablabla... let them get to the clinic first, besides $ALNY there first to grab the gold
July 18th 2017, 6:07am
bankerstribune @bankerstribune
Ladenburg Thalmann raised its target for Alnylam Pharmaceuticals $ALNY. This 10yr DCF supports rating change… https://t.co/ehmFLrrL09
July 18th 2017, 1:07am
SPNewsAnalysis @SPNewsAnalysis
Alnylam Pharmaceuticals, Inc. Expected to Post Q2 2017 Earnings of -$1.20 Per Share $ALNY https://t.co/shSXlko5Vh
July 18th 2017, 1:07am
intercooleronli @intercooleronli
Alnylam Pharmaceuticals, Inc. $ALNY Lowered to “Hold” at Zacks Investment Research https://t.co/VnU9ZBn21f
July 17th 2017, 4:07pm
ZolmaxNews @ZolmaxNews
Alnylam Pharmaceuticals, Inc. $ALNY Downgraded by Zacks Investment Research to Hold https://t.co/5hWQNcgZXN
July 17th 2017, 2:07pm
SPNewsAnalysis @SPNewsAnalysis
Alnylam Pharmaceuticals, Inc. $ALNY Given a $96.00 Price Target by Credit Suisse Group Analysts https://t.co/x6xJ5MQEiJ
July 17th 2017, 2:07pm
RNAiAnalyst @RNAiAnalyst
@who_can_tell looks like the $ALNY star is undergoing its supernova. any other interpretation of the paintings?
July 17th 2017, 2:07pm
WKRBNews @WKRBNews
Alnylam Pharmaceuticals, Inc. $ALNY Given “Buy” Rating at Cowen and Company https://t.co/QYdQn7G1SB
July 17th 2017, 1:07pm
WKRBNews @WKRBNews
Alnylam Pharmaceuticals, Inc. $ALNY Given “Buy” Rating at Cowen and Company https://t.co/ULLlYDlAgS
July 17th 2017, 1:07pm
dakotafinancial @dakotafinancial
Alnylam Pharmaceuticals, Inc. $ALNY Lifted to Buy at Zacks Investment Research https://t.co/THAC8b8SBr
July 17th 2017, 1:07pm
1LuckyJimmy @1LuckyJimmy
ALNY +0.91 total advance today 10:30 ET. Alnylam Pharmaceut $ALNY 79.65 Stock hit a High of 81.33 and 79.42 Lo https://t.co/zV5pmJIyuU
July 17th 2017, 11:07am
jfais20 @jfais20
$ALNY Ladenburg PT raise to $90 ahead of APOLLO readout, 80% probability of success
July 17th 2017, 9:07am
WatchlistN @WatchlistN
Ladenburg Thalmann Financial Services Increases Alnylam Pharmaceuticals, Inc. $ALNY Price Target to $90.00 https://t.co/MzJHH1uJ6B
July 17th 2017, 7:07am
twilli2861 @twilli2861
RT @diva_java: Who Are Non H2 Key Players of Alcoholic Steatohepatitis Pipeline (NASH)? https://t.co/qhRAqSDUQV #NASH $ALBO $ALNY https://t…
July 16th 2017, 1:07pm
diva_java @diva_java
Who Are Non H2 Key Players of Alcoholic Steatohepatitis Pipeline (NASH)? https://t.co/qhRAqSDUQV #NASH $ALBO $ALNY https://t.co/rQqx8YGtMU
July 16th 2017, 1:07pm
twilli2861 @twilli2861
RT @demycolton: Who Are Non H2 Key Players of Alcoholic Steatohepatitis Pipeline (NASH)? https://t.co/bV0jh0Qt05 #NASH $ALBO $ALNY https://…
July 16th 2017, 12:07pm
demycolton @demycolton
Who Are Non H2 Key Players of Alcoholic Steatohepatitis Pipeline (NASH)? https://t.co/bV0jh0Qt05 #NASH $ALBO $ALNY https://t.co/WNIkbMQCwd
July 16th 2017, 12:07pm
twilli2861 @twilli2861
RT @Demy_Colton: Who Are Non H2 Key Players of Alcoholic Steatohepatitis Pipeline (NASH)? https://t.co/i0TZYTj1NN #NASH $ALBO $ALNY https:/…
July 16th 2017, 11:07am
OneMedWorld @OneMedWorld
Who Are Non H2 Key Players of Alcoholic Steatohepatitis Pipeline (NASH)? https://t.co/srPKO0MDTI #NASH $ALBO $ALNY https://t.co/14bfQOb1vP
July 16th 2017, 10:07am
chaffeybreeze @chaffeybreeze
Alnylam Pharmaceuticals, Inc. $ALNY Given Buy Rating at Jefferies Group LLC https://t.co/B22d1lfpch
July 16th 2017, 4:07am
Demy_Colton @Demy_Colton
Who Are Non H2 Key Players of Alcoholic Steatohepatitis Pipeline (NASH)? https://t.co/i0TZYTj1NN #NASH $ALBO $ALNY https://t.co/z0Vj7uQMU8
July 16th 2017, 12:07am
TranscriptDaily @TranscriptDaily
Zacks: Brokerages Expect Alnylam Pharmaceuticals, Inc. $ALNY Will Announce Quarterly Sales of $22.22 Million https://t.co/GE0kNydwVK
July 15th 2017, 9:07am
intercooleronli @intercooleronli
Zacks: Brokerages Expect Alnylam Pharmaceuticals, Inc. $ALNY Will Announce Quarterly Sales of $22.22 Million https://t.co/sQGDpIqoav
July 15th 2017, 8:07am
SleekMoneycom @SleekMoneycom
Zacks: Brokerages Expect Alnylam Pharmaceuticals, Inc. $ALNY Will Announce Quarterly Sales of $22.22 Million https://t.co/Ec2jw2GJ14
July 15th 2017, 8:07am
dakotafinancial @dakotafinancial
Alnylam Pharmaceuticals, Inc. $ALNY Receives Average Recommendation of “Buy” from Analysts https://t.co/ptc8sHm32s
July 14th 2017, 8:07pm
TheMarketsDaily @TheMarketsDaily
Alnylam Pharmaceuticals, Inc. $ALNY Lifted to “Hold” at ValuEngine https://t.co/hlHhxamF9M
July 14th 2017, 7:07pm
emq_news @emq_news
Alnylam Pharmaceuticals, Inc. $ALNY Receives Average Recommendation of “Buy” from Analysts https://t.co/BXYPt6x6B4
July 14th 2017, 7:07pm
TickerReport @TickerReport
Alnylam Pharmaceuticals, Inc. $ALNY Receives Average Recommendation of “Buy” from Analysts https://t.co/VITb8l4ybH
July 14th 2017, 6:07pm
intercooleronli @intercooleronli
Alnylam Pharmaceuticals, Inc. $ALNY Receives Average Recommendation of “Buy” from Analysts https://t.co/yG8fkKhqWC
July 14th 2017, 6:07pm
TickerReport @TickerReport
Alnylam Pharmaceuticals, Inc. $ALNY Receives Average Recommendation of “Buy” from Analysts https://t.co/o4JDb3R9qz
July 14th 2017, 6:07pm
TranscriptDaily @TranscriptDaily
Alnylam Pharmaceuticals, Inc. $ALNY Receives “Equal Weight” Rating from Morgan Stanley https://t.co/ZztapqhK65
July 14th 2017, 6:07pm
dakotafinancial @dakotafinancial
Credit Suisse Group Analysts Give Alnylam Pharmaceuticals, Inc. $ALNY a $96.00 Price Target https://t.co/UYoc2FEPMY
July 14th 2017, 4:07pm
dakotafinancial @dakotafinancial
BlackRock Inc. Buys 4,732,617 Shares of Alnylam Pharmaceuticals, Inc. $ALNY https://t.co/GT2dF7LaAH
July 14th 2017, 12:07pm
dailypoliticaln @dailypoliticaln
Alnylam Pharmaceuticals’ $ALNY Buy Rating Reiterated at Needham & Company LLC https://t.co/UrgsqSFZVx
July 14th 2017, 10:07am
TheMarketsDaily @TheMarketsDaily
Alnylam Pharmaceuticals’ $ALNY “Buy” Rating Reaffirmed at Chardan Capital https://t.co/R2WOFFQC61
July 14th 2017, 10:07am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.